JAZZ News and Press, Jazz Pharmaceuticals plc From 04/21/20

DUBLIN , April 21, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 first quarter financial results on Tuesday, May 5, 2020 , after the close of the financial markets.  Company management will host a live audio webcast immedia...

Jazz Pharmaceuticals (NASDAQ: JAZZ ) initiated with Buy rating and $149 (51% upside) price target at Jefferies. More news on: Jazz Pharmaceuticals plc, Walgreens Boots Alliance, Inc., Acceleron Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...

DUBLIN , March 31, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today provided an update regarding the impact of COVID-19 on its business and the actions it is taking to mitigate the spread of this virus. "Jazz provides essential medicines to patients around the world an...

Under Priority Review status, the FDA has accepted Jazz Pharmaceuticals' (NASDAQ: JAZZ ) marketing application for JZP-258 for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older with narcolepsy. The agency's action date is July 21. More news o...

DUBLIN , March 25, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) accepted for filing with Priority Review the company's New Drug Application (NDA) seeking marketing approval for JZP-258, an investigationa...

Bull markets are born on pessimism, grown on skepticism, mature on optimism and die on euphoria. - Sir John Templeton One of the best times for you to invest in a stock is when it tumbled far below its true worth. This usually occurs during a downturn like this Corona bear market. Howeve...

Whether you're a novice investor who's just getting your feet wet or you've seen your fair share of bear markets, you've witnessed history over the past five weeks. In a span of 23 sessions since the S&P 500 hit its all-time closing high, the benchmark index has logged 10 of its 13 largest...

Just when you thought there were no more records left to be broken, Wall Street shows investors that it still has tricks up its sleeve. On Monday, investors witnessed something truly historic, and disheartening. Despite the Federal Reserve's best effort to calm already roiled markets with its...

The stock market is currently in a state of turmoil. Due to fears surrounding the rapid spread of the novel coronavirus around the world -- which has now been declared a pandemic by the World Health Organization (WHO) -- the three major U.S. stock market indexes have plunged. Furthermore, thi...

Allakos (NASDAQ: ALLK ) initiated with Underperform rating and $34 (42% downside risk) price target at SMBC Nikko. More news on: Allakos Inc., Avadel Pharmaceuticals plc, Krystal Biotech, Inc., Healthcare stocks news, Stocks on the move, , Read more ...